8-K: Hydrofarm Holdings Group Reports Second Quarter 2024 Results, Reaffirms Full-Year Outlook

Hydrofarm Holdings Group announced its second quarter 2024 financial results, highlighting cost savings and reaffirming its full-year 2024 outlook despite a decrease in net sales.

Summary

• Hydrofarm's net sales for the second quarter of 2024 decreased by 13.1% to $54.8 million compared to $63.1 million in the same period last year, primarily due to a 10.3% decline in volume/mix of products sold.
• The company's gross profit decreased to $10.9 million, or 19.8% of net sales, compared to $14.5 million, or 23.0% of net sales, in the prior year period.
• Adjusted gross profit decreased to $13.3 million, or 24.4% of net sales, compared to $17.0 million, or 27.0% of net sales, in the prior year period.
• Net loss increased to $23.5 million, or $(0.51) per diluted share, compared to a net loss of $12.9 million, or $(0.28) per diluted share, in the prior year period, which includes an $11.5 million non-cash loss from an asset sale.
• Adjusted EBITDA decreased to $1.7 million, compared to $2.5 million in the prior year period.
• The company had $30.3 million in cash and approximately $20 million of available borrowing capacity on its Revolving Credit Facility as of June 30, 2024.
• Hydrofarm generated $3.8 million in net cash from operating activities and $3.4 million in free cash flow during the quarter.
• The company reaffirmed its full-year 2024 outlook, expecting net sales to decrease in the low to high teens, positive adjusted EBITDA, and positive free cash flow.

Sentiment

Score: 5

Explanation: The sentiment is neutral to slightly negative. While the company is highlighting cost-saving measures and reaffirming its outlook, the financial results show a significant year-over-year decline in sales, gross profit, and adjusted EBITDA. The net loss is also substantially higher, indicating ongoing challenges. The positive outlook is tempered by the current financial performance.

Positives

• Hydrofarm achieved positive Adjusted EBITDA for the fourth time in the last five quarters, indicating the effectiveness of restructuring and cost-saving efforts.
• Adjusted Gross Profit Margin improved sequentially, driven by a focus on higher-margin proprietary brands and enhanced operational efficiency.
• The company reduced SG&A expenses by 20% year-over-year, demonstrating successful cost management.
• The completion of the IGE Asset Sale is expected to lower fixed costs and improve future profitability.
• Hydrofarm generated positive free cash flow of $3.4 million during the quarter.
• The company reaffirmed its full-year 2024 outlook, projecting positive adjusted EBITDA and free cash flow.
• The company has $30.3 million in cash and $20 million of available borrowing capacity.

Negatives

• Net sales decreased by 13.1% year-over-year, primarily due to a decline in volume/mix of products sold.
• Gross profit margin decreased to 19.8% from 23.0% year-over-year.
• Adjusted gross profit margin decreased to 24.4% from 27.0% year-over-year.
• Net loss increased to $23.5 million from $12.9 million year-over-year, including an $11.5 million non-cash loss from an asset sale.
• Adjusted EBITDA decreased to $1.7 million from $2.5 million year-over-year.
• Free cash flow decreased compared to the same period last year, primarily due to working capital changes.

Risks

• The market is impacted by oversupply and decreasing prices in the cannabis industry, which affects Hydrofarm's sales.
• If industry conditions worsen, the company may face additional impairment charges and liquidity challenges.
• The company's current stock prices are at depressed levels, making equity financing potentially dilutive.
• Interruptions in the supply chain could adversely impact sales growth and operations.
• The company may be unable to meet Nasdaq's continued listing standards.
• Restructuring activities may increase expenses and may not achieve the intended cost savings.
• The company operates in a highly competitive market, which could affect its ability to maintain or grow revenues.
• Changes in laws and regulations, particularly in the cannabis industry, could impact the market for the company's products.
• Damage to the company's reputation or its products could have an adverse effect on its business.
• The company's operations may be impaired if its information technology systems fail or if it is subject to a data breach or cyber-attack.
• The company may not be able to adequately protect its intellectual property.

Future Outlook

The company reaffirmed its full-year 2024 outlook, expecting net sales to decrease in the low to high teens, positive adjusted EBITDA, and positive free cash flow. They also anticipate improved year-over-year Adjusted Gross Profit Margin and reduced year-over-year Adjusted SG&A expense.

Management Comments

• Bill Toler, Chairman and Chief Executive Officer, stated that the company delivered positive Adjusted EBITDA for the fourth time in the last five quarters, illustrating the effectiveness of their restructuring plan and related cost savings efforts.
• He also mentioned that they increased their Adjusted Gross Profit Margin on a sequential basis, as they continue to strategically focus on higher margin proprietary brands and enhancing their operational efficiency.
• Management is confident in the company's long-term business fundamentals and growth opportunity, despite the current softness in the industry.

Industry Context

The company operates in the hydroponics equipment and supplies market, which is influenced by the cannabis industry. The oversupply in the cannabis market has negatively impacted Hydrofarm's sales. The potential rescheduling of cannabis is seen as a potential tailwind for the industry.

Comparison to Industry Standards

• Hydrofarm's performance is being compared to its own historical performance, particularly the prior year's results.
• The company is focusing on improving its adjusted gross profit margin, which is a key metric for profitability in the manufacturing and distribution sector.
• The company's cost-cutting measures, including restructuring and SG&A reductions, are common strategies in the current economic environment.
• The company's focus on proprietary brands is a strategy to differentiate itself from competitors and improve margins.
• The company's debt structure is typical for companies in its sector, with a mix of term loans and revolving credit facilities.

Stakeholder Impact

• Shareholders may be concerned about the decrease in net sales and the increase in net loss.
• Employees may be affected by ongoing restructuring and cost-saving initiatives.
• Customers may benefit from the company's focus on higher-quality proprietary brands.
• Suppliers may be impacted by changes in the company's manufacturing and distribution operations.
• Creditors will be monitoring the company's debt levels and cash flow.

Next Steps

• The company will continue to focus on cost-saving initiatives and improving operational efficiency.
• Hydrofarm will continue to focus on higher-margin proprietary brands.
• The company will monitor industry demand and potential tailwinds, such as the possible rescheduling of cannabis.
• The company will host a conference call to discuss the financial results.

Key Dates

Keywords

hydroponics, controlled environment agriculture, cannabis, net sales, gross profit, adjusted EBITDA, free cash flow, restructuring, cost savings, asset sale, SG&A, proprietary brands